PUF-I is a critical modulator of transcriptional activity in pituitary cells and has a central role in the stimulation of prolactin gene transcription in the mammalian pituitary lactotroph.
During pituitary development, a proportion of cells (lactotrophs) acquire the ability to produce and secrete a protein hormone, prolactin. The onset of this cell-specific protein synthesis is apparently controlled at the level of prolactin RNA transcription. The elucidation of the mechanism involved in the activation of prolactin gene transcription in the lactotrophic cells may, therefore, provide important information toward the understanding of the complex process of pituitary cell differentiation.
The regulated transcription of eucaryotic genes is mediated through the complex interaction of multiple trans-acting protein factors with various cis-acting control elements (6, 19) . Recently, studies have suggested the involvement of a cell-specific protein factor in the transcriptional regulation of the rat prolactin gene (3, 11, 21) . Using an in vitro transcription system, we previously demonstrated that efficient transcription of the rat prolactin RNA was mediated by a positive-acting protein factor present in pituitary-derived GH3 cells. In addition, footprint analysis revealed that a GH3 nuclear factor interacts specifically with a DNA region located from -63 to -36 upstream from the prolactin RNA initiation site. This binding region consists of an 18-base-pair A+T-rich imperfectly symmetrical sequence and an additional 10 base pair sequence downstream. More significantly, in vitro transcription experiments with deletion templates confirmed that the A+T-rich region was essential for the cell-specific control of prolactin transcription (E. A. Barron, Z. Cao, B. G. Schneider, E. Kraig, A. J. Carrillo, and Z. D. Sharp, submitted for publication). On the basis of these observations, we speculated that the prolactin DNAbinding protein, which we named prolactin upstream factor I (PUF-I) (3), was a cell-specific transcription factor which stimulates the transcription of the prolactin gene and, perhaps, other pituitary-specific genes.
In this paper, we report the purification of PUF-I from pituitary-derived GH3 cells. By DNA sequence-specific affinity chromatography, the PUF-I protein was enriched 10,000-to 20,000-fold. We demonstrated that the purified PUF-I was able to promote the transcription of the rat prolactin gene when combined with nuclear transcription extracts prepared from nonpituitary cells. We also provided evidence that the effect of PUF-I to stimulate transcription was directly correlated with its ability to bind to the A+T-rich sequence in the prolactin promoter. These results support the suggestion that PUF-I is a pituitary protein transcription factor that has a major role in the efficient expression of the prolactin gene in the mammalian pituitary.
MATERIALS AND METHODS Preparation of nuclear extracts. GH3 cells were grown in Ham F-10 medium supplemented with 10% fetal calf serum and 2.5% horse serum. HeLa cells were cultured in Eagle minimal essential medium (Irvine Scientific) with 10% fetal calf serum, and PC12 cells were grown in RPMI 1640 medium (GIBCO Laboratories, Grand Island, N.Y.) with 10% serum. The cells were harvested with 0.03% EDTA in Puck saline, and the nuclear extracts were prepared by the procedure of Dignam et al (5) .
Preparation of sequence-specific DNA affinity column. A DNA sequence-specific resin was prepared by the method of Kadonaga and Tjian (13), using the following DNA sequences:
After annealing and ligation of the oligonucleotides, the DNA was covalently linked to CNBr-activated Sepharose CL-2B-300 (Sigma Chemical Co., St. Louis, Mo.). The coupling rate was estimated to be 22 jig of DNA per ml of resin.
Purification of PUF-I. GH3 nuclear extract (35 ml, 6 mg of protein per ml, prepared from about 35 g of cells) was loaded on 25 ml of heparin-agarose (Bio-Rad Laboratories, Richmond, Calif.) equilibrated with 20 mM HEPES (N-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (pH 7.9)-0.1 mM EDTA-0.5 mM dithiothreitol-0.1 M KCl-0.1 mM phenylmethylsulfonyl fluoride-20% glycerol. The flowthrough was collected, and the bound proteins were eluted with the same buffer containing a 0.1 to 1.0 M KCl gradient. The fractions that showed specific DNA-binding and transcription activities were pooled and prepared for DNA affinity column chromatography (13) by dialysis against the column buffer, 25 mM HEPES (pH 7.9)-0.1 M KCl-6.0 mM EDTA-1.0 mM dithiothreitol-0.1% Nonidet P-40-20% glycerol. Poly(dIdC)-(dI-dC) was added to 10 ,ug/ml, and after a 10-min incubation, the protein-DNA mixture was loaded onto the DNA sequence-specific affinity column at a ratio of 30 mg of protein per ml of column. The resin was mixed with the protein extract and allowed to stand for 10 min. The flowthrough was then collected, and the resin was washed four PROLACTIN UPSTREAM FACTOR I 5433 times with 2 column volumes of buffer containing 0.1 M KCl and four times with buffer containing 0.2 M KCI. The bound proteins were eluted with 1.0 M KCI and dialyzed against the 0.1 M KCI column buffer, and poly(dI-dC)-(dI-dC) was added to 3.0 pug/ml. This material was reapplied to the column and eluted by the same procedure that was utilized on passage 1. The proteins in sample from each passage were precipitated with trichloroacetic acid and suspended in loading buffer for analysis by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis.
DNase I footprint analysis. The DNA templates used for footprint analyses (9) were fragments of rat prolactin DNA containing the region from -174 to +39 or from -110 to +39. The DNA fragments were labeled at the 5' end of the coding strand with T4 polynucleotide kinase (Pharmacia LKB Biotechnology, Inc., Piscataway, N.J.). Protein-DNA binding reactions were carried out in a volume of 40 ,u containing 20 mM HEPES (pH 7.9), 1.0 mM EDTA, 1.0 mM dithiothreitol, 0.1 M KCI, 10% glycerol, 20,000 cpm of labeled prolactin DNA (0.5 to 1.0 ng), and 1.0 pLg of poly(dI-dC) (dI-dC). Bovine serum albumin (3 ,ug) was added to the reaction mixtures containing affinity-purified PUF-I. After incubation on ice for 30 min, 2.0 ,ul of freshly prepared DNase I mix containing 0.01 mg of DNase I per ml, 50 mM CaCl2, and 200 mM MgCl2 was added to the reaction mixture. The digestions were terminated in 60 s by the addition of 60 pAl of a stop mix composed of 67 mM EDTA, 0.5 M sodium acetate, and 83 ,ug of tRNA per ml. After phenol-chloroform extraction, the DNA fragments were precipitated and analyzed by sequencing gel electrophoresis followed by autoradiography.
In vitro transcription. The conditions for in vitro transcription and primer extension assays were the same as previously described (3). The prolactin DNA template used in the assays were plasmid pHSX-420, which contained the region from -420 to +600 with an 11-base-pair SalI linker inserted at the Avall site located at +32 (Barron et al., submitted). The major primer extension product obtained with this template was 83 nucleotides long. The control template included in the reactions was plasmid HTX-B containing three copies of the adenovirus major late promoter (kindly provided by J. Corden). Transcripts from the control template yielded a 54-nucleotide primer extension product in our assays.
The construction of the point-mutated templates, including the A58(A--C),51(T--G) plasmid used in this study, will be described in detail elsewhere. Briefly, single-base mutations were introduced into the PUF-I-binding region by oligonucleotide-directed mutagenesis by the thionucleotide method (25, 26) . The altered plasmids were selected by hybridization with a prolactin oligonucleotide hybridization probe, and the exact nucleotide alterations in the prolactin promoter were verified by dideoxy sequencing.
RESULTS
PUF-I purification. Heparin-agarose column chromatography was used as the initial step to enrich for PUF-I. Approximately 200 mg of nuclear proteins was applied to the column, and the bound proteins were eluted with a linear KCI gradient. In vitro prolactin transcription assays demonstrated that fractions 15 through 21 (corresponding to 0.4 to 0.6 M KCI) were able to transcribe the gene accurately and efficiently (Fig. 1) . By gel shift assays (8), the PUF-I DNAbinding activity was detected in fractions 14 3 4 5 6 7 8 9 10 FIG. 1. In vitro transcription of the rat prolactin gene with heparin-agarose fractions. The transcription and primer extension conditions were the same as described previously (3). Each transcription reaction contained 500 ng of plasmid pHSX-420, which contains the HindIII-XbaI (-420 to +600) fragment of rat prolactin DNA. The primer extension product generated by this template is indicated (PRL). Lane 1, Transcription result with 15 Ill of unfractionated GH3 nuclear extract. Lane 2, Inability of the flowthrough (FT) to generate detectable prolactin RNA. Lanes 3 to 10, Prolactin in vitro transcription assays with 10-,ul samples from the salt gradient fractions (indicated above the lanes). As shown in lanes 6 to 9, fractions 15 to 21 were able to transcribe detectable levels of prolactin RNA in vitro and were subsequently pooled for affinity chromatography.
activity. This purification step resulted in a five-to sevenfold enrichment of the DNA-binding activity of PUF-I versus protein mass.
Heparin-agarose fractions that showed specific DNA binding and transcription function were pooled, dialyzed, and applied to the prolactin DNA sequence-specific affinity column. The DNA affinity column was constructed with oligonucleotides which contained the PUF-I-binding region (see Materials and Methods for the exact sequence). The proteins retained on the column were step eluted with KCI, and the fractions were then assayed for PUF-I-binding activity by DNase I footprint analyses. The results indicated that the PUF-I protein was dissociated from the matrix by 1.0 M KCI (Fig. 2, lanes 8 to 11) .
To obtain a higher degree of purification, the high-salt fraction was dialyzed and the proteins were reapplied to the column and eluted as before. An SDS-polyacrylamide gel electrophoretic analysis was performed to estimate the protein composition of the material from each passage. The first pass through the column removed the majority of nonspecific proteins, and the second pass further eliminated highermolecular-weight proteins (Fig. 3) . The proteins resolved on an SDS-gel at approximately 33.0 and 34.5 kilodaltons were significantly enriched by the first pass through the DNA affinity column (Fig. 3, lane 2) and are considered to be the best candidates for the PUF-I protein. The indication that the PUF-I activity is a doublet could mean that there are two forms of the same protein or two different proteins. The smaller band at approximately 29 kilodaltons which appeared on the second pass (Fig. 3, lane 3) was not observed in either the crude (Fig. 3, lane 1) or the first-pass (Fig. 3 I protection (Fig. 4, lanes 5 to 7) . An estimated purification of 10,000-to 20,000-fold was calculated on the basis of specific DNA-binding activity per mass of protein.
Purified PUF-I activates enhanced prolactin transcription in nonpituitary extracts. We have previously shown that nuclear extracts prepared from nonpituitary cells were unable to efficiently transcribe the prolactin gene from the +1 site. These extracts also failed to demonstrate protection of the A+T-rich region by DNase I footprint analyses (3). To determine whether the purified PUF-I was capable of enhancing prolactin RNA synthesis, we reconstituted transcription in nonpituitary extracts supplemented with the protein preparation containing highly enriched PUF-I. (15) . A sample (20 ,lI) of the pooled heparin-agarose (HA) fractions containing PUF-I-binding activity (lane 1) and 50 and 80 p.l of the 1.0 M KCI eluate from the passage 1 and 2 affinity columns (lanes 2 and 3, respectively) were precipitated with trichloroacetic acid, dissolved in 20 p.l of SDS-gel loading buffer, and subjected to electrophoresis. The gel was silver stained by a modification of the method described by Wray et al. (27) . The molecular size markers are indicated in kilodaltons.
HeLa or PC12 extracts alone produced low levels of prolactin RNA (Fig. 5, lanes 3 and 6, respectively) . The transcriptional competence of these extracts was illustrated by their ability to actively transcribe the major late promoter (Fig. 5, lanes 3 and 6) . No transcriptional activity was observed in the reaction in which PUF-I was used alone (Fig. 5, lane 2) . When combined with either HeLa or PC12 extracts, however, PUF-I specifically promoted prolactin transcription initiated from the major (+1) site in a concentration-dependent manner (Fig. 5 , lanes 4 and 5 and 7 and 8, respectively). This transcriptional enhancement was promoter selective because the transcriptional level of the major late template remained the same or, in some cases, showed a decrease in activity (Fig. 5, lanes 4 and 5 and 7 and 8 , respectively). These results strongly suggest that the low level of prolactin gene transcription in nonpituitary cells is due, at least partially, to the low abundance or inactivity of PUF-I in these cells. PUF-I activates transcription of rat prolactin gene by binding to the 5' A+T-rich region. To determine whether DNA binding is required for enhanced prolactin transcription in vitro, we tested a PUF-I-binding region point mutation, A58(A-*C),51(T-*G), for its ability to bind PUF-I and reproduce cell-specific transcription. This mutation consisted of base substitutions at positions -58 (A to C) and -51 (T to G) (Fig. 6C) . Footprint analysis showed that these two base changes severely impaired the ability of the purified PUF-I to bind to this region (Fig. 6A , compare lanes 2 to 4 with lanes 6 to 8). Prolactin gene transcription was also dramatically reduced in GH3 in vitro transcription assays with the A58(A--C),51(T-->G) template (Fig. 6B, compare lanes 1 and  2) .
In vitro reconstitution of enhanced prolactin transcription with PUF-I and HeLa extracts was also performed with the mutated and wild-type templates. In contrast to the wildtype promoter, the A58(A--C),51(T--+G) template was not responsive to the addition of PUF-I to produce increased transcripts initiated from the + 1 site (Fig. 6B, counting. These results (not shown) demonstrated that there was an approximately fourfold reduction in GH3-specific transcription from the +1 site with the A58(A--C),51(T--+G) template compared with the wild type. Consistent with this finding, there was no increase in prolactin transcription in reconstituted assays with A58(A-*C),51(T-->G) compared with a threefold increase with the wild-type prolactin promoter. These results establish a definite relationship between the A+T-rich binding region and the prolactin promoter enhancement function of the PUF-I protein.
Interestingly, the addition of PUF-I preparation to HeLa extract reduced the minor class of prolactin transcripts initiated from -27 when wild-type template was used (Fig. 6,  compare lanes 4 and 5) . This observation supports the hypothesis that the PUF-I-protected region contains two discrete promoter sequences, a TATA element that directs RNA initiation from -27 and an element that interacts with PUF-I to enhance +1 transcription (Barron et al., submit- No prolactin -27 transcripts were visualized when the mutated template was used regardless of the presence of PUF-I (Fig. 6 , lanes 2, 6, and 7). A possible explanation is that the base substitutions also impaired the TATA function that resides within the A+T-rich sequence.
DISCUSSION
The existence of a cell-specific transcription factor responsible for prolactin gene expression in pituitary lactotrophs was suggested by in vitro transcription and protein-DNA binding assays (3, 11, 21) . Taking advantage of the specific DNA-binding property of this protein factor, we used DNA sequence-specific affinity chromatography as the major step in its purification. This approach was successful in enriching the binding and transcription activity approximately 10,000-to 20,000-fold.
We believe that the PUF-I activity is represented by the doublet of proteins with approximate molecular masses of 33.0 and 34.5 kilodaltons. This judgment is based on the enrichment of these bands during the purification steps. Nelson et al. (21) used UV cross-linking to demonstrate that the binding of a GC nuclear factor to a PUF-I binding region probe appeared as a doublet with molecular masses of 43.5 and 43.0 kilodaltons. We cannot explain the inconsistency of these results, but it is likely to be the consequence of technical differences in the experiments. The precise molecular weight of PUF-I will be determined when a sufficient amount can be gel purified and renatured to demonstrate binding and transcriptional enhancement.
Regardless of its exact molecular weight, the highly enriched PUF-I from the second passage bound to the same prolactin promoter region as crude GH3 nuclear extracts and was clearly able to promote the enhanced + 1 transcription of the rat prolactin gene in vitro when combined with HeLa and PC12 extracts.
Nelson et al. (21) reported that a protein factor (Pit-I) from pituitary-derived GC cells is apparently able to interact with four proximal sites (including the PUF-I-binding site) and four distal sites located in about a 2.0-kilobase region of the prolactin 5'-flanking region. Based on gene transfer methods, it was suggested that a synergistic action of these regions is important for cell-specific transcriptional regulation (22) . However, deletion mutagenesis and in vitro transcription assays do not reveal any alteration in transcriptional efficiency of the prolactin promoter until the -63 to -46 A+T-rich binding region is deleted (3; Barron et al., submitted). If PUF-I binding is important for the in vivo function of the distal elements, why is the influence of the other binding sites not observed in vitro? We think that there are two possible answers to this question. The first is technical; one PUF-I-binding region is sufficient to elicit the maximal transcriptional response possible in an in vitro system. The second possibility is that the distal elements require a certain chromatin configuration to exert their transcriptional effects. Point mutagenesis of the distal binding sites will determine more precisely whether they have a significant role in pituitary-specific enhancement of prolactin gene transcription.
The data presented here clearly showed that enhanced transcription mediated by PUF-I depends on a specific . At the early stages of pituitary development, most of the prolactin-producing cells also appeared to synthesize growth hormone, and it is possible that mammotrophs differentiate from somatotrophs (12) . Is PUF-I a developmentally regulated protein which is expressed during the differentiation of the pituitary somatotroph and lactotroph? The study of the transcriptional regulation of other pituitary-specific proteins may provide more insight into the function of PUF-I in development.
The prolactin gene is capable of responding to a wide variety of extracellular substances (4, 10, 17, 18, 20, 23, 24) . Therefore, it is exciting that the PUF-I-binding region was also recently reported to mediate the transcription-activating effect of epidermal growth factor and phorbol esters (7) . In addition, the transcriptional inhibition of the estrogen receptor is possibly mediated through an interaction with a PUF-I-like protein (1) . Protein factors that translate hormonal effects have been shown to act as transcription factors in in vitro studies (2, 14, 16 ). This effect is accomplished possibly through protein-protein interactions or through other pathways which modify the DNA-binding ability or the transcriptional activation function of the factor. It is reasonable to postulate that PUF-I is a critical intermediate in these regulatory pathways that has the interesting property of being able to interact with other positive and negative transcription factors and with the general factors of transcription initiation as well.
